A pharmaceutical composition for treating or remedying chronic myelogenous leukemia

摘要

This application discloses that as an active ingredient it is possible to use all low dose amounts of (2S) -2 - [(2S, 3R) -3-amino-2-hydroxy-4-phenylbutanoylamino] -4- methylpentanoic acid or its pharmacological (3-pyridinyl) -2-pyrimidinyl] amino] - RTI ID = 0.0 & Phenyl] -benzamide or a pharmacologically acceptable salt thereof for the treatment or remission of chronic myelogenous leukemia.